HT17. COVID-19 vaccinated individuals may be ill…See more

What Comes Next
The research opens several avenues for future work. One important direction is developing strategies to reduce the risk of myocarditis without compromising the protective immune response that makes mRNA vaccines so effective. Genistein represents one candidate, though the path from laboratory findings to clinical application involves extensive additional research.

Another area of interest is understanding why young males are disproportionately affected. The role of hormonal differences in shaping immune responses is an active area of investigation, and genistein’s estrogen-like activity hints at one possible dimension of this story.